Changes between Version 44 and Version 45 of NIAID2024

Timestamp:

Dec 5, 2024, 2:05:39 PM (11 months ago)

Author:

Elaine Meng

Comment:

--

NIAID2024

@@ -100 +100 @@
 Discussion of licensing issues with alphafold 3.
 
-Lenicapivir is new and exciting HIV drug and program officer Dave McDonald got a ChimeraX session from the grantee and came to the bioviz lab to view it in VR.  So another way to stimulate use is to say that it may help get funding for structural biology projects, by communicating interesting findings to granting agencies in an engaging way.
+Lenacapivir is new and exciting HIV drug and program officer Dave McDonald got a ChimeraX session from the grantee and came to the bioviz lab to view it in VR.  So another way to stimulate use is to say that it may help get funding for structural biology projects, by communicating interesting findings to granting agencies in an engaging way.
 
 TomF: is it unique to NIAID?  Meghan: we are unique in that we have the bioviz lab available to the program officers.  Other institutes may not have their own, although ours is available to other institutes. NIAID research has priority but if facilities are available, it's fine for others to make use of them.
+
+Meghan mentions a report that suggested communication needs to improve, as well as splitting NIAID into Allergy vs. Infectious Disease. Elaine: sounds the opposite of some other proposals to drastically decrease the number of institutes.
+[https://oversight.house.gov/wp-content/uploads/2024/12/12.04.2024-SSCP-FINAL-REPORT.pdf big ol' report PDF] and the resulting
+[https://oversight.house.gov/wp-content/uploads/2024/12/2024.12.04-SSCP-FINAL-REPORT-RECOMMENDATIONS.pdf recommendations PDF] (shorter)
+
+TomG: what about non-VR usage in the agenda. 3D printing?  Phil: we can bring some 3D prints with us. Elaine: what about regular old desktop/laptop usage? 
+
+TomF: did you know about the impending release of ChimeraX 1.9? TomG: we're aiming for next week.
+
+Phil: I want to schedule time to sit down with TomG about getting the most out of !LookSee. Issues with markers. TomG: I've had problems too, have been communicating with Meta tech support, but they were not very helpful.  Meghan: do you have to be a developer? TomG: join a release channel. Meghan: we can test things, let us know. Phil: I like the controls to simplify a scene.
+
+Meghan: in San Mateo (Meta?), Luke De is program manager for global learning and development. Maybe we can reconnect with him on our visit. TomG: that would be great, better than the first-level tech support.
+
+TomF: how many days are you thinking about?  Meghan: always happy to stay longer. Maybe travel Mon and Fri, 3 full business days Tu-Th.
+
+Meghan: is anybody working on viz of light-sheet microscopy? TomG: yes, Dyche Mullins and Nico Stuurman who builds the microscopes.
+
+ACTION ITEM: get back to the NIAID with dates please. TomG: we are somewhat at a loss without Scooter.  Meghan: if you give us the dates and figure out the rooms and to some extent the agenda, we can do the rest.
 
 [=#notes112124]